Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes
about
Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccinationEmergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina FasoMetabolic shift in the emergence of hyperinvasive pandemic meningococcal lineagesEffect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18.Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.Modeling the cost-effectiveness of the integrated disease surveillance and response (IDSR) system: meningitis in Burkina Faso.Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from AfricaMolecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.Genetic diversity of Neisseria meningitidis serogroup C ST-4821 in China based on multiple-locus variable number tandem repeat analysis.Bexsero® chronicle.Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.Application of multiple-locus variable number tandem repeat analysis to identify outbreak-associated Neisseria meningitides serogroup C sequence type 4821 in China.Sequence, distribution and chromosomal context of class I and class II pilin genes of Neisseria meningitidis identified in whole genome sequences.Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7Carriage of Neisseria meningitidis serogroup W135 ST-2881Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.Fast and accurate dynamic estimation of field effectiveness of meningococcal vaccinesPrevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccineCarriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization.Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectivesMeningococcal disease in South Africa, 1999-2002.Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.The epidemiology of meningococcal disease and the impact of vaccines.Glycoconjugate vaccines: an update.Serogroup A meningococcal conjugate vaccines in Africa.Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.Characterization of Neisseria meningitidis isolates from Egypt using multilocus sequence typing.Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains.[Epidemic meningitis in 2013 in Republic of Guinea: Nesseria meningitidis W135 emergence].Synthesis and immunological evaluation of protein conjugates of Neisseria meningitidis X capsular polysaccharide fragments.Serogroup W135 meningococcal meningitis, Northern Cameroon, 2007-2008.Avidity of IgG antibodies against meningococcal serogroup a polysaccharide and correlations with bactericidal activity in sera from meningitis patients and controls from Ethiopia.Conjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives.Emergence and genomic diversification of a virulent serogroup W:ST-2881(CC175) Neisseria meningitidis clone in the African meningitis belt.
P2860
Q28659784-07DA72C0-9C86-46B5-8F33-90690D0D89ACQ28744396-CF9CBCF0-5C64-4272-866E-7008B49A0854Q30397794-9BDF2F91-2147-4588-87AB-C02D73FB0078Q30566557-1277376B-CA23-4547-9CF5-98AA88D23C4EQ33274203-8F877BAC-CCE5-4939-A841-F78F896052BEQ33565201-41061657-F543-43C9-88FD-59A6D85B1071Q33712087-6C1FB08A-E5EC-447E-BB69-766E3666A611Q34039044-57B77626-9FB8-4269-BCA7-7F158435D959Q34430626-42962825-326E-401E-B911-D2E757340136Q34431744-224CC080-7F6E-445E-9621-ABC899372682Q34465908-20A7B50B-5D31-49A1-80E2-F89E21CF5877Q34562726-51BF1104-221B-4E63-A837-6D1A65C23F7AQ34707962-2DC85DA1-84EB-41D7-8585-21AA1BCFFA86Q34785389-70602216-4B63-436E-A145-43F4DCC8111BQ34892719-1BA5A5E3-1C76-4621-8FFC-CA5A2BAB7B62Q34989418-FBD9950F-CADF-4036-B234-B90301D434C2Q35137074-DF8ACA8A-B41D-42F0-B215-A0D40E8AA847Q35198778-8B215845-79F9-4F06-BE99-94BF8642CD9AQ35783511-504694C8-A166-444A-9800-2F0CB0D63047Q35805707-0DB801AE-F468-4D31-BB7C-9F7D9D86BCC1Q35920353-1F57A276-E971-4BEC-83E1-E632238B0AA7Q36065267-EA7D5A20-DDE7-458F-93F0-D95C9F351772Q36183088-C19D7FE8-F5CD-4CCF-803A-DE813F2B6EEDQ36414192-4D0ABC07-757A-4602-90DD-85FD548FB539Q36530211-82E5427E-A496-41A1-BCE2-15195B275C80Q37144776-57804DC2-DEF0-483B-B7CF-ED92213EA71DQ37302664-23A29ED4-23D0-42E7-8DE5-5CD182A9C6A2Q37473667-33EFF8D2-BBF4-4424-9F2E-36C7B818DD51Q37706585-9B8B1089-FFB8-4000-9757-67EDC879871CQ38286346-844BAFD7-1273-4B01-95C5-2670AF239B22Q38584375-93A9F888-235E-449A-90E5-A64518E38432Q38606992-CD558D64-4794-44CC-A13F-6FB5106D322FQ39140508-3A5EFA98-2E61-448C-B632-E1D41D204907Q39537767-F390C089-2818-449A-90E4-60BAEEBA7577Q40557399-28453D9B-3707-47E3-B496-54CFB6E95D41Q41669855-0A89B3DF-84A4-47E2-9B65-D516723E019EQ41861796-0E6F2B5F-1C94-48C9-A16C-1EF050511ABBQ42234518-E8C8DC92-2243-458F-ABB4-7669A61832A9Q42287903-3006E3C2-0892-4F5A-B883-021DBB519648Q42363077-8A83FB41-B8D4-414D-9C88-57CFCC5CE3B3
P2860
Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Molecular epidemiology of neis ...... e 5 (ST-5) and ST-11 complexes
@ast
Molecular epidemiology of neis ...... e 5 (ST-5) and ST-11 complexes
@en
Molecular epidemiology of neis ...... s dominance of sequence type 5
@nl
type
label
Molecular epidemiology of neis ...... e 5 (ST-5) and ST-11 complexes
@ast
Molecular epidemiology of neis ...... e 5 (ST-5) and ST-11 complexes
@en
Molecular epidemiology of neis ...... s dominance of sequence type 5
@nl
prefLabel
Molecular epidemiology of neis ...... e 5 (ST-5) and ST-11 complexes
@ast
Molecular epidemiology of neis ...... e 5 (ST-5) and ST-11 complexes
@en
Molecular epidemiology of neis ...... s dominance of sequence type 5
@nl
P2093
P2860
P921
P1476
Molecular epidemiology of neis ...... e 5 (ST-5) and ST-11 complexes
@en
P2093
Dominique A Caugant
Eric Garnotel
Pierre Nicolas
Saacou Djibo
P2860
P304
P356
10.1128/JCM.43.10.5129-5135.2005
P407
P577
2005-10-01T00:00:00Z